Getinge (GETI B.ST) Osake Kurssi
Getinge Kurssi
Liikevaihto on kasvanut 5,3 % vuodessa viimeisten 19 vuoden aikana 34,97 Mrd. SEK:een. Osakekohtainen tulos on kasvanut 3,1 % vuodessa viimeisten 19 vuoden aikana. Getingen nettomarginaali on nyt 6,5 %, laskenut 11,0 %:sta muutama vuosi sitten. Getingen osinkotuotto on tällä hetkellä noin 1,67 %. Jakosuhde on noin 55 % tuloksesta. Osinko on kasvanut 4,7 % vuodessa viimeisten 19 vuoden aikana. Analyytikoiden mediaanitavoitehinta on 231,03 SEK, eli ali nykyhintaa 16,2 %. 14 analyytikosta 8 suosittaa ostoa — kokonaiskonsensus on Osta.
Getinge osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Getinge liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Getinge -osakkeesta
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analyytikot asettavat tällä hetkellä Getinge-osakkeelle keskimääräisen tavoitehinnan 238,81 SEK (mediaani: 231,03 SEK), mikä merkitsee −13,4 % viimeisimpään hintaan verrattuna. Konsensus perustuu 14 analyytikkoarvioon.
14 analyytikkoa arvioi tällä hetkellä Getinge-osaketta: 8 suosittaa ostoa, 5 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat Getinge-yhtiöltä 35,26 Mrd. SEK liikevaihtoa ja 12,89 SEK osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Getinge-osake noteerataan hintaan 25,03 EUR (275,80 SEK).
Getinge-osake (GETI B.ST) on listattuna 9 pörssissä, muun muassa: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
odotettu liikevaihto Getinge on 35,26 Mrd. SEK. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Getinge on 3,51 Mrd. SEK. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Getinge:n hinta-voitto-suhde (P/E) on tällä hetkellä 21,40. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Getinge-osakkeen arvostusta.
Getinge:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,13. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Getinge-osakkeen arvostuskennuslukuna.
Getinge:n Eulpool-laatuscore on 4/10.
Getinge:n ISIN on SE0000202624. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Getinge:n WKN on 889714. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Getinge:n ticker on GETI B.ST. Tämä pörssinoteeraus käytetään Getinge-osakkeiden kauppaan pörssissä.
Getinge osake
Getinge vertaisryhmä
Getinge Ticker
Getinge FIGI
Kaikki tunnusluvut ja syvällinen analyysi Getinge:sta
Meidän osakeanalyysimme Getinge-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Getinge:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: